Health Care: Drugs

Protalix BioTherapeutics Inc (PLX: AMEX)

$0.66 0.0159 | 2.47%
07/27/16 - 03:58 PM ET
Company Profile
Price and Volume
Recent Price 0.64
52 Week High 1.75
52 Week Low 0.61
Avg. Daily Vol. (Mil) 0.08
Beta (3 year) 0.21
Share Related Items
Mkt Cap (Mil) 64.29
Shares Out (Mil) 99.81
Float (Mil) 83.08
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.20
Current Ratio 8.20
LT Debt/ Equity 27.25
Total Debt / Equity 27.25
Valuation Ratios
Price Earnings 1.10
Price/Sales -1.19K
Price/Book 24.26
Price/Cash Flow 1.10
Per Share Data
Earnings 0.59
Sales 0.00
Book Value 0.03
Cash Flow 0.58
Business Summary
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system, or ProCellEx.
General Information
2 Snunit Street
Science Park, POB 455
Carmiel, 20100
Industry : Drugs
Sector: Health Care
Employees: 223
CEO: Moshe Manor
Short Interest
Current Month (Mil) 0.79
Previous Month (Mil) 0.86
Short Interest Ratio (Days) 8.70
Management Effectiveness
Return on Equity 2,091.00
Return on Assets 63.50
Return on Investments 74.00
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with PLX

Latest PLX Headlines from TheStreet

More Financial News for PLX

Press Releases for PLX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter